found that supplementation with alpha-tocopherol may prevent ESCC by modulating the PPAR γ-Akt signaling pathway and attenuating NF-κB activation and CXCR3-mediated inflammation without effect in the late stage of ESCC carcinogenesis (29, 30). Here, CXCR3 is linked to esophageal squamous cell carcinoma.